The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine

The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression

(2018) Smruti Pushalkar et al.   Cancer Discovery

Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies

(2018) Concetta Panebianco et al.   Microbiome

Host cell attachment elicits posttranscriptional regulation in infecting enteropathogenic bacteria

(2017) Naama Katsowich et al.   SCIENCE

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

(2017) Leore T. Geller et al.   SCIENCE

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer

(2017) E. Giovannetti et al.   SEMINARS IN CANCER BIOLOGY

Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential

(2017) Bok Hee Woo et al.   Oncotarget

Pancreatic Cancer Chemoresistance to Gemcitabine

(2017) Manoj Amrutkar et al.   Cancers

Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

(2016) Joseph Ciccolini et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment

(2016) Tessa Y.S. Le Large et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study

(2016) Xiaozhou Fan et al.   GUT

FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer

(2016) Chiara Caparello et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Stroma, Stroma Everywhere (Far More Than You Think)

(2015) K. P. Olive   CLINICAL CANCER RESEARCH

Microenvironmental regulation of therapeutic response in cancer

(2015) Florian Klemm et al.   TRENDS IN CELL BIOLOGY

Local bacteria affect the efficacy of chemotherapeutic drugs

(2015) Panos Lehouritis et al.   Scientific Reports

Microbiota, Oral Microbiome, and Pancreatic Cancer

(2014) Dominique S. Michaud et al.   CANCER JOURNAL

Nucleoside-catabolizing Enzymes in Mycoplasma-infected Tumor Cell Cultures Compromise the Cytostatic Activity of the Anticancer Drug Gemcitabine

(2014) Johan Vande Voorde et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Microbiology: Microbiome science needs a healthy dose of scepticism

(2014) William P. Hanage   NATURE

Impact of tumour associated macrophages in pancreatic cancer

(2013) Ainhoa Mielgo et al.   BMB Reports

Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met-driven Pancreatic Carcinoma

(2013) A. Avan et al.   CANCER RESEARCH

Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase

(2013) N Weizman et al.   ONCOGENE

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study

(2012) Dominique S Michaud et al.   GUT

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

(2011) James J Farrell et al.   GUT